End-of life medical spending and care pathways in the last 12 months of life: A comprehensive analysis of the national claims database in France

Background:To inform policy makers on efficient provision of end-of-life care, we estimated the 12-month medical expenditures of French decedents in 2015. Methods:We estimated total medical expenditures by service type and diagnosis category, and analyzed care pathways for breast cancer, dementia, chronic obstructive lung disease. Results:501,121 individuals died in 2015, 59% of whom were in a hospital at the time of death. The aggregated spending totaled 9% of total health expenditures, a mean of euro28,085 per capita, 44% of which was spent during the last 3 months of life. Hospital admissions represented over 70% of total expenditures; 21.3% of the population used hospital palliative care services in their last year of life. Analyses performed on breast cancer, dementia and lung disease found that differences in care pathways markedly influenced spending and were not simply explained by patients characteristics. Conclusion:Diagnoses and care trajectories, including repeated hospital stays, are the main drivers of the last year of life expenditures. Our data suggests that early identification of patients requiring palliative care and community-based end-of-life service delivery is feasible and could better support patients, families and caregivers with constant or reduced costs.

Automated summary

In order to inform policy makers on the efficient provision of end-of-life care, the 12-month medical expenditures of French decedents in 2015 were estimated. The results showed that 59% of the decedents were in a hospital at the time of death, with aggregated spending totaling 9% of total health expenditures. The mean expenditure per capita was euro28,085, with 44% of it being spent during the last 3 months of life.